Nexentis Technologies Inc.

Contributing Author

Recent Articles by Nexentis Technologies Inc.

May-18	Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development NXTS +10.76% GlobeNewswire
May-13	Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone NXTS GlobeNewswire
May-05	Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX's Algorithm Platform MITOLINE NXTS GlobeNewswire
Mar-13	Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform NXTS GlobeNewswire